The use of recombinant human erythropoietin stimulating factor in plastic surgery.

Aesthetic plastic surgery 2004 Vol.28(3) p. 174-6

Ferraro GA, Corcione A, Nicoletti GF, Brongo S, Ciccarelli F, D'Andrea F

관련 도메인

Abstract

Erythropoietin is the most important factor in the regulation of erythropoiesis. This study aimed to evaluate the efficacy of rhuESF for patients undergoing plastic surgical procedures during which notable blood loss is expected (reduction mammoplasty in cases of macromastia and abdominoplasty obese patients) to improve the full blood count and reduce the need for transfusion. The levels of hemoglobin were significantly greater for patients pretreated with erythropoietin and iron than for the control group.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 reduction mammoplasty 유방성형술 dict 1
시술 abdominoplasty 복부성형술 dict 1
해부 blood scispacy 1
약물 iron C0302583
iron
scispacy 1
질환 blood loss C0019080
Hemorrhage
scispacy 1
질환 macromastia C0020565
Hypertrophy of Breast
scispacy 1
기타 human erythropoietin stimulating factor scispacy 1
기타 Erythropoietin scispacy 1
기타 patients scispacy 1
기타 hemoglobin scispacy 1

MeSH Terms

Adult; Blood Loss, Surgical; Blood Transfusion, Autologous; Erythropoietin; Female; Hemoglobins; Humans; Iron; Male; Mammaplasty; Middle Aged; Obesity; Recombinant Proteins; Time Factors; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문